This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

I may be mistaken but I think I heard of some people being prescribed Rituxan in the past to treat their ms even if it hasn't been officially approved for ms yet. I know that Campath can have some pretty serious potential side effects. My question is; do you think someone could ever be able to receive a prescription for Campath before it is officially approved for ms?

I am currently in southern Spain for a long weekend. Weather is lovely c. 22C / 75F. Sitting on the beach reading my newspaper this morning I see the following story about Campath. I hope this young woman sees the good results I have seen.

Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 26 September 2007

Genzyme Corporation and Bayer Schering Pharma AG, Germany today announced that the first patient has been treated in the first of two planned Phase 3 trials examining the safety and efficacy of alemtuzumab for the treatment of multiple sclerosis (MS).

The CARE-MS I trial (Comparison of Alemtuzumab and Rebif Efficacy in ...

The Food and Drug Administration will allow Genzyme Corp. to continue human tests of a new multiple sclerosis drug that caused a fatal bleeding disease in one trial patient, the company said yesterday.

The drug, Campath, is a cancer treatment that has showed promise as a once-a-year infusion for multiple sclerosis patients.

hello everyone i was on betaferon but developed anti bodies so was asked to go on a trial to try and "flip" the antibodies my antibodies did not "flip" so my neuroligist put me on capaxone have been on it for nearly 12 months and every four weeks or so i keep getting immediate post injection reaction with dizziness,heart palpitations and difficulty breathing.I am just so over this whole MS thing!!!!! doesnt it know that ...

When I was first diagnosed in May 2004, I came across articles on Campath on the UK MS Society website. There was a link to a patient with very active RRMS (David's story) who set out his experience. His diary ended pretty much after his second infusion. Two years on, he has provided an update - set out below. He seems to be doing well.

"Analysis of the first co-primary endpoint showed that patients taking alemtuzumab at high and low doses experienced at least a 75 percent reduction in the risk for relapse after at least two years of follow up when compared to patients treated with interferon beta-1a."

That's pretty amazing because they're not saying a 75% overall reduction, they're seeing a 75% reduction compared to Rebif! And the Campath patients have only had 2 infusions ...

This site does not offer, or claim to offer, medical, legal, or professional advice.
All treatment decisions should always be made with the full knowledge of your physicians.
This is MS does not create, endorse, or republish any content.
All postings are the responsibility of the poster. All logos and trademarks in this site are property of their respective owners. All users must respect our rules for intellectual property rights.